Suppr超能文献

相似文献

1
Effects of elfamycins on elongation factor Tu from Escherichia coli and Staphylococcus aureus.
Antimicrob Agents Chemother. 1989 Mar;33(3):322-5. doi: 10.1128/AAC.33.3.322.
2
Synthetic analogs of aurodox and kirromycin active on elongation factor Tu from Escherichia coli.
J Antibiot (Tokyo). 1981 Aug;34(8):1039-45. doi: 10.7164/antibiotics.34.1039.
4
Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu.
Proc Natl Acad Sci U S A. 1974 Dec;71(12):4910-4. doi: 10.1073/pnas.71.12.4910.
8
Characterization of a kirromycin-resistant elongation factor Tu from Escherichia coli.
Biochemistry. 1981 Mar 3;20(5):1355-61. doi: 10.1021/bi00508a049.
10
The structural and functional basis for the kirromycin resistance of mutant EF-Tu species in Escherichia coli.
EMBO J. 1994 Oct 17;13(20):4877-85. doi: 10.1002/j.1460-2075.1994.tb06815.x.

引用本文的文献

1
Identification of an antibiotic from an HTS targeting EF-Tu:tRNA interaction: a prospective topical treatment for MRSA skin infections.
Appl Environ Microbiol. 2025 Jan 31;91(1):e0204624. doi: 10.1128/aem.02046-24. Epub 2024 Dec 23.
2
New Insights into the Mechanism of Action of L-681,217, a Medicinally Promising Polyketide Inhibitor of Bacterial Protein Translation.
Biochemistry. 2024 Dec 17;63(24):3336-3347. doi: 10.1021/acs.biochem.4c00541. Epub 2024 Nov 22.
3
Comparison of Antibiotic Resistance Mechanisms in Antibiotic-Producing and Pathogenic Bacteria.
Molecules. 2019 Sep 21;24(19):3430. doi: 10.3390/molecules24193430.
4
A population genomics approach to exploiting the accessory 'resistome' of .
Microb Genom. 2017 Apr 6;3(4):e000108. doi: 10.1099/mgen.0.000108. eCollection 2017 Apr.

本文引用的文献

1
Penicillin-binding proteins in a Staphylococcus aureus strain resistant to specific beta-lactam antibiotics.
Antimicrob Agents Chemother. 1982 Jul;22(1):172-5. doi: 10.1128/AAC.22.1.172.
2
A mutant elongation factor Tu which does not immobilize the ribosome upon binding of kirromycin.
Eur J Biochem. 1981 Jun;117(1):7-12. doi: 10.1111/j.1432-1033.1981.tb06295.x.
3
Molecular properties of two mutant species of the elongation factor Tu.
Eur J Biochem. 1981 Jun;117(1):1-6. doi: 10.1111/j.1432-1033.1981.tb06294.x.
4
Kirromycin-resistant elongation factor Tu from wild-type of Lactobacillus brevis.
FEBS Lett. 1982 Sep 20;146(2):322-6. doi: 10.1016/0014-5793(82)80944-7.
6
Synthetic analogs of aurodox and kirromycin active on elongation factor Tu from Escherichia coli.
J Antibiot (Tokyo). 1981 Aug;34(8):1039-45. doi: 10.7164/antibiotics.34.1039.
7
Protein synthesis in a cell-free extract from Staphylococcus aureus.
J Bacteriol. 1967 Jul;94(1):80-6. doi: 10.1128/jb.94.1.80-86.1967.
8
Studies on the purification and properties of factor Tu from E. coli.
Arch Biochem Biophys. 1970 Nov;141(1):26-37. doi: 10.1016/0003-9861(70)90102-5.
9
Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu.
Proc Natl Acad Sci U S A. 1974 Dec;71(12):4910-4. doi: 10.1073/pnas.71.12.4910.
10
Mechanism of action of kirromycin-like antibiotics.
Annu Rev Microbiol. 1985;39:557-77. doi: 10.1146/annurev.mi.39.100185.003013.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验